These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 12877450

  • 1. Patient perceptions of an inhaled asthma medication administered as an inhalation powder via the Diskus or as an inhalation aerosol via a metered-dose inhaler.
    Sheth K, Bernstein JA, Lincourt WR, Merchant KK, Edwards LD, Crim CC, Dorinsky PM.
    Ann Allergy Asthma Immunol; 2003 Jul; 91(1):55-60. PubMed ID: 12877450
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids.
    You-Ning L, Humphries M, Du X, Wang L, Jiang J.
    Int J Clin Pract; 2005 Jul; 59(7):754-9. PubMed ID: 15963199
    [Abstract] [Full Text] [Related]

  • 3. Ease of handling and clinical efficacy of fluticasone propionate Accuhaler/Diskus inhaler compared with the Turbohaler inhaler in paediatric patients. UK Study Group.
    Williams J, Richards KA.
    Br J Clin Pract; 1997 Jul; 51(3):147-53. PubMed ID: 9293055
    [Abstract] [Full Text] [Related]

  • 4. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [Abstract] [Full Text] [Related]

  • 5. Concurrent use of metered-dose and dry powder inhalers by children with persistent asthma does not adversely affect spacer/inhaler technique.
    Chan DS, Callahan CW, Hatch-Pigott VB, Lawless A, Proffitt HL, Manning NE, Schweikert MP.
    Ann Pharmacother; 2006 Oct; 40(10):1743-6. PubMed ID: 16968822
    [Abstract] [Full Text] [Related]

  • 6. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 7. A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients.
    Pieters WR, Stallaert RA, Prins J, Greefhorst AP, Bosman HG, van Uffelen R, Schreurs AJ, van Helmond JL, Janssen PG.
    J Asthma; 1998 Jul; 35(4):337-45. PubMed ID: 9669827
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
    Wardlaw A, Larivee P, Eller J, Cockcroft DW, Ghaly L, Harris AG.
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):49-55. PubMed ID: 15281471
    [Abstract] [Full Text] [Related]

  • 9. Patient perception of the diskus inhaler: a comparison with the turbuhaler inhaler.
    Schlaeppi M, Edwards K, Fuller RW, Sharma R.
    Br J Clin Pract; 1996 Jul; 50(1):14-9. PubMed ID: 8729596
    [Abstract] [Full Text] [Related]

  • 10. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS.
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [Abstract] [Full Text] [Related]

  • 11. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

  • 12. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]

  • 13. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K, Noonan M, Silkoff PE, Uryniak T.
    Clin Ther; 2007 Jun 29; 29(6):1013-26. PubMed ID: 17692718
    [Abstract] [Full Text] [Related]

  • 14. Fluticasone propionate plasma concentration and systemic effect: effect of delivery device and duration of administration.
    Whelan GJ, Blumer JL, Martin RJ, Szefler SJ, Asthma Clinical Research Network and the Pediatric Pharmacology Research Unit Network.
    J Allergy Clin Immunol; 2005 Sep 29; 116(3):525-30. PubMed ID: 16159619
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
    Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
    Respir Med; 2008 Apr 29; 102(4):495-504. PubMed ID: 18206361
    [Abstract] [Full Text] [Related]

  • 16. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
    Pearlman DS, Noonan MJ, Tashkin DP, Goldstein MF, Hamedani AG, Kellerman DJ, Schaberg A.
    Ann Allergy Asthma Immunol; 1997 Apr 29; 78(4):356-62. PubMed ID: 9109702
    [Abstract] [Full Text] [Related]

  • 17. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma.
    Wasserman SI, Gross GN, Schoenwetter WF, Munk ZM, Kral KM, Schaberg A, Kellerman DJ.
    J Asthma; 1996 Apr 29; 33(4):265-74. PubMed ID: 8707781
    [Abstract] [Full Text] [Related]

  • 18. Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma.
    Wolfe J, Kreitzer S, Chervinsky P, Lawrence M, Wang Y, Reilly D, Davis S, Stahl E.
    Ann Allergy Asthma Immunol; 2000 Mar 29; 84(3):334-40. PubMed ID: 10752919
    [Abstract] [Full Text] [Related]

  • 19. [Influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients].
    Miyagawa T.
    Arerugi; 2008 Nov 29; 57(11):1134-44. PubMed ID: 19052508
    [Abstract] [Full Text] [Related]

  • 20. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP, Hill MR, Vaughan LM, Meltzer EO, Welch MJ, Ostrom NK.
    Ann Allergy Asthma Immunol; 1997 Oct 29; 79(4):322-6. PubMed ID: 9357377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.